A Role for Germline Variants in Multiple Myeloma?

被引:0
|
作者
Walker, Brian A. [1 ]
机构
[1] Indiana Univ Sch Med, Melvin & Bren Simon Comprehens Canc Ctr, Div Hematol & Oncol, Indianapolis, IN USA
来源
BLOOD CANCER DISCOVERY | 2024年 / 5卷 / 06期
关键词
D O I
10.1158/2643-3230.BCD-24-0226
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In Blood Cancer Discovery, Thibaud and colleagues report the incidence of pathogenic germline variants (PGV) in patients with multiple myeloma and that these PGVs are associated with DNA repair pathway genes, including BRCA1 and BRCA2. They find an association of patients with PGVs and previous family or personal history of cancer, and that these patients are diagnosed slightly earlier than those without PGVs. Patients with PGVs had a longer progression-free survival than those without PGVs when they received high-dose melphalan and autologous stem cell transplant, providing a therapeutic rationale for diagnostic germline testing in myeloma. See related article by Thibaud et al., p. 428
引用
收藏
页码:375 / 376
页数:2
相关论文
共 50 条
  • [21] The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
    Sharma, Neeraj
    Smadbeck, James B.
    Abdallah, Nadine
    Zepeda-Mendoza, Cinthya
    Binder, Moritz
    Pearce, Kathryn E.
    Asmann, Yan W.
    Peterson, Jess F.
    Ketterling, Rhett P.
    Greipp, Patricia T.
    Bergsagel, P. Leif
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    Baughn, Linda B.
    CLINICAL CANCER RESEARCH, 2021, 27 (19) : 5430 - 5439
  • [22] Germline Variation Predicts Treatment Response in Multiple Myeloma
    Roter, Kyle
    Hu, Donglei
    Clay-Gilmour, Alyssa
    Huntsman, Scott
    Shah, Nina D.
    Wong, Sandy W.
    Martin, Thomas G., III
    Wolf, Jeffrey Lee
    Binder, Moritz
    Kumar, Shaji K.
    Rajkumar, S. Vincent
    Slager, Susan L.
    Vachon, Celine M.
    Ziv, Elad
    BLOOD, 2019, 134
  • [23] Germline Risk Contribution to Genomic Instability in Multiple Myeloma
    Janz, Siegfried
    Zhan, Fenghuang
    Sun, Fumou
    Cheng, Yan
    Pisano, Michael
    Yang, Ye
    Goldschmidt, Hartmut
    Hari, Parameswaran
    FRONTIERS IN GENETICS, 2019, 10
  • [24] Pathogenic germline mutations in a large cohort of multiple myeloma
    Fang, Teng
    Sun, Hao
    Hao, Mu
    Qiu, Lugui
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S68 - S69
  • [25] Novel germline APC variants in patients with multiple adenomas
    Pedemonte, S
    Sciallero, S
    Gismondi, V
    Stagnaro, P
    Biticchi, R
    Haeouaine, A
    Bonelli, L
    Nicolo, G
    Groden, J
    Bruzzi, P
    Aste, H
    Varesco, L
    GENES CHROMOSOMES & CANCER, 1998, 22 (04): : 257 - 267
  • [26] Confirmed Pathogenic Germline Variants in Cancer Predisposition Genes Incidentally Detected in Somatic Genomic Profiling of Multiple Myeloma Patients
    Thibaud, Santiago
    Genthe, William
    Bodnar, Saoirse
    Lagana, Alessandro
    Houldsworth, Jane
    Chari, Ajai
    Rossi, Adriana C.
    Rodriguez, Cesar
    Sanchez, Larysa J.
    Richard, Shambavi
    Richter, Joshua
    Onel, Kenan
    Jagannath, Sundar
    Brander, Tehilla
    Parekh, Samir
    BLOOD, 2023, 142
  • [27] Multiple rare germline variants in a thyroid cancer family
    Nieminen, Taina T.
    Comiskey, Daniel F.
    Wang, Yanqiang
    Liyanarachchi, Sandya
    Brock, Pamela
    Peltomaki, Paivi
    He, Huiling
    de la Chapelle, Albert
    CANCER RESEARCH, 2019, 79 (13)
  • [28] Revealing the Impact of Structural Variants in Multiple Myeloma
    Rustad, Even H.
    Yellapantula, Venkata D.
    Glodzik, Dominik
    Maclachlan, Kylee H.
    Diamond, Benjamin
    Boyle, Eileen M.
    Ashby, Cody
    Blaney, Patrick
    Gundem, Gunes
    Hultcrantz, Malin
    Leongamornlert, Daniel
    Angelopoulos, Nicos
    Agnelli, Luca
    Auclair, Daniel
    Zhang, Yanming
    Dogan, Ahmet
    Bolli, Niccolo
    Papaemmanuil, Elli
    Anderson, Kenneth C.
    Moreau, Philippe
    Avet-Loiseau, Herve
    Munshi, Nikhil C.
    Keats, Jonathan J.
    Campbell, Peter J.
    Morgan, Gareth J.
    Landgren, Ola
    Maura, Francesco
    BLOOD CANCER DISCOVERY, 2020, 1 (03): : 258 - 273
  • [29] MULTIPLE MYELOMA - SOME CLINICAL AND PROTEIN VARIANTS
    DEXTER, MW
    DAVIS, RL
    LAWTON, AH
    STEWART, EB
    MILITARY MEDICINE, 1961, 126 (07) : 487 - +
  • [30] Common, germline genetic variants within the Wnt/beta-catenin stem cell pathway as determinants of multiple myeloma risk
    Hildebrandt, Michelle A. T.
    Ye, Yuanqing
    Zhou, Yeling
    Orlowski, Robert
    Wu, Xifeng
    CANCER RESEARCH, 2014, 74 (19)